Alpha-1 antitrypsin expression is upregulated in multidrug-resistant cancer cells.

Divac Rankov, Aleksandra; Jovanovic Stojanov, Sofija; Dragoj, Miodrag; Ljujic, Mila

Divac Rankov, Aleksandra; Jovanovic Stojanov, Sofija; Dragoj, Miodrag; Ljujic, Mila.

Afiliação

Divac Rankov A; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Jovanovic Stojanov S; Department of Neurobiology, Institute for Biological Research "Sinisa Stankovic" - National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.
Dragoj M; Department of Neurobiology, Institute for Biological Research "Sinisa Stankovic" - National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.
Ljujic M; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia. milaljujic@imgge.bg.ac.rs.

Histochem Cell Biol ; 159(5): 431-437, 2023 May.

Article em En | MEDLINE | ID: mdl-36536187

Assuntos

Resistência a Múltiplos Medicamentos; Glioblastoma; Humanos; Glioblastoma/tratamento farmacológico; Glioblastoma/genética; Interleucina-6; Resistencia a Medicamentos Antineoplásicos

Palavras-chave

Alpha-1 antitrypsin; Cancer; Chemoresistance; SERPINA1; Therapy resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma / Resistência a Múltiplos Medicamentos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google